{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T08:18:18Z","timestamp":1770970698904,"version":"3.50.1"},"reference-count":33,"publisher":"Wiley","issue":"3","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":3471,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Acta Paediatrica"],"published-print":{"date-parts":[[2006,3,1]]},"DOI":"10.1080\/08035250500434785","type":"journal-article","created":{"date-parts":[[2006,1,10]],"date-time":"2006-01-10T20:55:24Z","timestamp":1136926524000},"page":"332-339","source":"Crossref","is-referenced-by-count":11,"title":["Osteogenesis imperfecta: Anthropometric, skeletal and mineral metabolic effects of long-term intravenous pamidronate therapy"],"prefix":"10.1111","volume":"95","author":[{"given":"Alfredo","family":"Vallo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francisco","family":"Rodriguez-Leyva","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juan","family":"Rodr\u00edguez Soriano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","reference":[{"key":"E00001","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1136\/jmg.16.2.101","volume":"16","author":"Sillence DO","year":"1979","unstructured":"Sillence, DO and Senn, A and Danks, DM. (1979) Genetic heterogeneity in osteogenesis imperfecta <i>J Med Genet<\/i>, 16, pp. 101 - 16.","journal-title":"J Med Genet"},{"key":"E00002","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1056\/NEJM199810013391402","volume":"339","author":"Glorieux FH","year":"1998","unstructured":"Glorieux, FH and Bishop, NJ and Plotkin, H and Chabot, G and Lanoue, G and Travers, R. (1998) Cyclic administration of pamidronate in children with severe osteogenesis imperfecta <i>N Engl J Med<\/i>, 339, pp. 947 - 52.","journal-title":"N Engl J Med"},{"key":"E00003","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1210\/edrv.19.1.0325","volume":"19","author":"Fleisch H.","year":"1998","unstructured":"Fleisch, H. (1998) Bisphosphonates: mechanisms of action <i>Endocrin Rev<\/i>, 19, pp. 80 - 100.","journal-title":"Endocrin Rev"},{"key":"E00004","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1136\/adc.86.5.356","volume":"86","author":"Astrom A","year":"2002","unstructured":"Astrom, A and Soderhall, S. (2002) Beneficial effect of long term intravenous bisphophonate treatment of osteogenesis imperfecta <i>Arch Dis Child<\/i>, 86, pp. 356 - 64.","journal-title":"Arch Dis Child"},{"key":"E00005","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1016\/S1297-319X(02)00434-7","volume":"69","author":"Giraud F","year":"2002","unstructured":"Giraud, F and Meunier, FJ. (2002) Effect of intravenous pamidronate therapy in children with osteogenesis imperfecta. Open-label study in seven patients <i>Joint Bone Spine<\/i>, 69, pp. 486 - 90.","journal-title":"Joint Bone Spine"},{"key":"E00006","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1542\/peds.111.3.573","volume":"111","author":"Falk MJ","year":"2003","unstructured":"Falk, MJ and Heeger, S and Lynch, KA and DeCaro, KR and Bohach, D and Gibson, KS and (2003) Intravenous bisphosphonate therapy in children with osteogenesis imperfecta <i>Pediatrics<\/i>, 111, pp. 573 - 8.","journal-title":"Pediatrics"},{"key":"E00007","doi-asserted-by":"crossref","first-page":"e601","DOI":"10.1542\/peds.111.5.e601","volume":"111","author":"Montpetit K","year":"2003","unstructured":"Montpetit, K and Plotkin, H and Rauch, F and Bilodeau, N and Clouthier, S and Rabzel, M and (2003) Rapid increase in grip force after start of pamidronate therapy in children and adolescents with severe osteogenesis imperfecta <i>Pediatrics<\/i>, 111, pp. e601 - 3.","journal-title":"Pediatrics"},{"key":"E00008","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1016\/j.bone.2004.07.003","volume":"35","author":"Dimeglio LA","year":"2004","unstructured":"Dimeglio, LA and Ford, L and McClintock, C and Peacock, M. (2004) Intravenous pamidronate treatment in children under 36 months of age with osteogenesis imperfecta <i>Bone<\/i>, 35, pp. 1038 - 45.","journal-title":"Bone"},{"key":"E00009","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1542\/peds.111.5.1030","volume":"111","author":"Zeiltin L","year":"2003","unstructured":"Zeiltin, L and Rauch, F and Plotkin, H and Glorieux, FX. (2003) Height and weight development during four years of therapy with cyclical intravenous pamidronate in children and adolescents with osteogenesis imperfecta types I, III and IV <i>Pediatrics<\/i>, 111, pp. 1030 - 6.","journal-title":"Pediatrics"},{"key":"E00010","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1136\/adc.83.2.143","volume":"83","author":"Shaw NJ","year":"2000","unstructured":"Shaw, NJ and Bovin, CM and Crabtree, NJ. (2000) Intravenous pamidronate in juvenile osteoporosis <i>Arch Dis Child<\/i>, 83, pp. 143 - 5.","journal-title":"Arch Dis Child"},{"key":"E00011","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1136\/adc.83.2.143","volume":"83","author":"Shaw NJ","year":"2000","unstructured":"Hern\u00e1ndezM, CastelletJ, NarvaizaJL, Rinc\u00f3nJM, RuizE, S\u00e1nchezE, <i>Growth graphics and tables<\/i> . Madrid: Garci Ed.; 1988.","journal-title":"Arch Dis Child"},{"key":"E00012","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1007\/s00467-004-1465-5","volume":"19","author":"Sch\u00f6nau E.","year":"2004","unstructured":"Sch\u00f6nau, E. (2004) The peak bone mass concept: is it still relevant? <i>Pediatr Nephrol<\/i>, 19, pp. 825 - 31.","journal-title":"Pediatr Nephrol"},{"key":"E00013","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1002\/jbmr.5650070204","volume":"7","author":"Carter DR","year":"1992","unstructured":"Carter, DR and Bouxsein, ML and Marcus, R. (1992) New approaches for interpreting projected bone morphometry data <i>J Bone Miner Res<\/i>, 7, pp. 137 - 45.","journal-title":"J Bone Miner Res"},{"key":"E00014","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1097\/00005176-200501000-00014","volume":"40","author":"Olsen IE","year":"2005","unstructured":"Olsen, IE and Ittenbach, RF and Rovner, AJ and Leonard, MB and Mulberg, AE and Stallings, VA and (2005) Deficits in size-adjusted bone mass in children with Alagille syndrome <i>J Pediatr Gastroenterol Nutr<\/i>, 40, pp. 76 - 82.","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"E00015","first-page":"4702","volume":"84","author":"Bachrach LK","year":"1999","unstructured":"Bachrach, LK and Hastie, T and Wang, M-C and Narasimhan, B and Marcus, R. (1999) Bone mineral acquisition in healthy Asian, Hispanic, black, and Caucasian youth: a longitudinal study <i>J Clin Endocrinol Metab<\/i>, 84, pp. 4702 - 12.","journal-title":"J Clin Endocrinol Metab"},{"key":"E00016","doi-asserted-by":"crossref","first-page":"1658","DOI":"10.1359\/jbmr.2001.16.9.1658","volume":"16","author":"Ellis KJ","year":"2001","unstructured":"Ellis, KJ and Shypailo, RJ and Hardin, DS and Perez, MD and Motil, KJ and Wong, WW and (2001) Z score prediction model for assessment of bone mineral content in pediatric patients <i>J Bone Miner Res<\/i>, 16, pp. 1658 - 64.","journal-title":"J Bone Miner Res"},{"key":"E00017","first-page":"1846","volume":"85","author":"Plotkin HG","year":"2000","unstructured":"Plotkin, HG and Rauch, F and Bishop, J and Monpetit, K and Rick-Gibis, J and Travers, R and (2000) Pamidronate treatment of severe osteogenesis imperfecta in children under 3 years of age <i>J Clin Endocrinol Metab<\/i>, 85, pp. 1846 - 50.","journal-title":"J Clin Endocrinol Metab"},{"key":"E00018","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/S8756-3282(99)00186-6","volume":"25","author":"Vieira NE","year":"2000","unstructured":"Vieira, NE and Goans, RE and Weiss, GH and Hopkins, E and Marini, JC and Yergey, AL. (2000) Calcium kinetics in children with osteogenesis imperfecta, types III and IV: pre- and post-growth hormone therapy. Calcif Tissue Int 67:97\u2013100 <i>Bone<\/i>, 25, pp. 501 - 5.","journal-title":"Bone"},{"key":"E00019","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1359\/jbmr.2003.18.2.237","volume":"18","author":"Marini JC","year":"2003","unstructured":"Marini, JC and Hopkins, E and Glorieux, FX and Chrousos, GP and Reynolds, JC and Gundberg, CM and (2003) Positive linear growth and bone responses to growth hormone treatment in children with types III and IV osteogenesis imperfecta: high predictive value of the carboxyterminal propeptide of type 1 procollagen <i>J Bone Miner Res<\/i>, 18, pp. 237 - 43.","journal-title":"J Bone Miner Res"},{"key":"E00020","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1515\/JPEM.2002.15.2.217","volume":"15","author":"Noda H","year":"2002","unstructured":"Noda, H and Onishi, H and Saitoh, K and Nakajima, H. (2002) Growth hormone therapy may increase fracture risk in a pubertal patient with osteogenesis imperfecta <i>J Pediatr Endocrinol Metab<\/i>, 15, pp. 217 - 8.","journal-title":"J Pediatr Endocrinol Metab"},{"key":"E00021","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1172\/JCI0217051","volume":"110","author":"Lindsay R.","year":"2002","unstructured":"Lindsay, R. (2002) Modeling the benefits of pamidronate in children with osteogenesis imperfecta <i>J Clin Invest<\/i>, 110, pp. 1239 - 41.","journal-title":"J Clin Invest"},{"key":"E00022","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1172\/JCI0215952","volume":"110","author":"Rauch F","year":"2002","unstructured":"Rauch, F and Travers, R and Plotkin, H and Glorieux, FX. (2002) The effects of intravenous pamidronate on the bone tissue of children and adolescents with osteogenesis imperfecta <i>J Clin Invest<\/i>, 110, pp. 1293 - 9.","journal-title":"J Clin Invest"},{"key":"E00023","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1007\/s004310100844","volume":"160","author":"Lee YS","year":"2001","unstructured":"Lee, YS and Low, SL and Lim, LA and Loke, KY. (2001) Cyclic pamidronate infusion improves bone mineralization and reduces fracture incidence in osteogenesis imperfecta <i>Eur J Pediatr<\/i>, 160, pp. 641 - 4.","journal-title":"Eur J Pediatr"},{"key":"E00024","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1359\/jbmr.2003.18.4.610","volume":"18","author":"Rauch F","year":"2003","unstructured":"Rauch, F and Plotkin, H and Zeitlin, L and Glorieux, FX. (2003) Bone mass, size, and density in children and adolescents with osteogenesis imperfecta: effect of intravenous pamidronate therapy <i>J Bone Miner Res<\/i>, 18, pp. 610 - 4.","journal-title":"J Bone Miner Res"},{"key":"E00025","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1515\/JPEM.2004.17.11.1511","volume":"17","author":"Zacharin M","year":"2004","unstructured":"Zacharin, M and Kanumakala, S. (2004) Pamidronate treatment of less severe forms of osteogenesis imperfecta <i>J Pediatr Endocrinol Metab<\/i>, 17, pp. 1511 - 7.","journal-title":"J Pediatr Endocrinol Metab"},{"key":"E00026","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1210\/jc.2002-021371","volume":"88","author":"Rauch F","year":"2003","unstructured":"Rauch, F and Plotkin, H and Travers, R and Zeitklin, L and Glorieux, FX. (2003) Osteogenesis imperfecta types I, III and IV: effect of pamidronate therapy on bone and mineral metabolism <i>J Clin Endocrinol Metab<\/i>, 88, pp. 986 - 92.","journal-title":"J Clin Endocrinol Metab"},{"key":"E00027","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/S0022-3476(05)81038-8","volume":"119","author":"Chines A","year":"1995","unstructured":"Chines, A and Boniface, A and McAlister, W and Whyte, MP. (1995) Hypercalciuria in children severely affected with osteogenesis imperfecta <i>J Pediatr<\/i>, 119, pp. 51 - 7.","journal-title":"J Pediatr"},{"key":"E00028","doi-asserted-by":"crossref","first-page":"2006","DOI":"10.1111\/j.1523-1755.2005.00302.x","volume":"67","author":"Vezzoli G","year":"2005","unstructured":"Vezzoli, G and Soldati, L and Arcidiacono, T and Terranegra, A and Biasion, R and Russo, CR and (2005) Urinary calcium as a determinant of bone mineral density in elderly men participating in the InCHIANTI study <i>Kidney Int<\/i>, 67, pp. 2006 - 14.","journal-title":"Kidney Int"},{"key":"E00029","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1093\/ndt\/17.8.1396","volume":"17","author":"Freundlich M","year":"2002","unstructured":"Freundlich, M and Alonzo, F and Bellorin-Font, E and Weisinger, JR. (2002) Reduced bone mass in children with idiopathic hypercalciuria and in their asymptomatic mothers <i>Nephrol Dial Transplant<\/i>, 17, pp. 1396 - 401.","journal-title":"Nephrol Dial Transplant"},{"key":"E00030","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1093\/ndt\/17.8.1396","volume":"17","author":"Freundlich M","year":"2002","unstructured":"Rodr\u00edguez-SorianoJ, ValloA, AguirreM.Bone mineral density and bone turnover in patients with Bartter syndrome. <i>Pediatr Nephrol<\/i> 2005;20:1120\u20135.","journal-title":"Nephrol Dial Transplant"},{"key":"E00031","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.jbspin.2003.09.009","volume":"71","author":"Legroux-Gerot I","year":"2004","unstructured":"Legroux-Gerot, I and Catanzariti, L and Marchandise, X and Duquesnoy, B and Cortet, B. (2004) Bone mineral density changes in hypercalciuretic osteoporotic men treated with thiazide diuretics <i>Joint Bone Spine<\/i>, 71, pp. 51 - 5.","journal-title":"Joint Bone Spine"},{"key":"E00032","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1097\/01.mnh.0000133974.24935.fe","volume":"13","author":"Lee T","year":"2004","unstructured":"Lee, T and Surendran, K and Zawaideh, MA and Mathew, S and Hruska, KA. (2004) Bone morphogenetic protein 7: a novel treatment for chronic renal and bone disease <i>Curr Opin Nephrol Hypertens<\/i>, 13, pp. 417 - 22.","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"E00033","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1523-1755.2004.00355.x","volume":"65","author":"Schiavi S","year":"2004","unstructured":"Schiavi, S and Kumar, R. (2004) The phosphatonin pathway: new insights in phosphate homeostasis <i>Kidney Int<\/i>, 65, pp. 1 - 14.","journal-title":"Kidney Int"}],"container-title":["Acta Paediatrica"],"original-title":[],"link":[{"URL":"http:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1080%2F08035250500434785","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1080\/08035250500434785\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,2,10]],"date-time":"2021-02-10T16:38:54Z","timestamp":1612975134000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1080\/08035250500434785"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,3,1]]},"references-count":33,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2006,3,1]]}},"alternative-id":["Q491226177J3V42N"],"URL":"https:\/\/doi.org\/10.1080\/08035250500434785","relation":{},"ISSN":["0803-5253"],"issn-type":[{"value":"0803-5253","type":"print"}],"subject":[],"published":{"date-parts":[[2006,3,1]]}}}